African swine fever (ASF) is a severe viral disease affecting domestic and wild pigs. Wide use of swine fever vaccine can effectively block the transmission of ASF virus, offering immunity to pigs. The vaccine helps prevent economic losses to farmers and safeguards the local pork supply. The vaccine consists of live attenuated ASF virus that produces high-level, long-lasting immunity with a single dose administration. The global swine fever vaccine market provides effective prevention against the widespread African swine fever disease. An increasing number of pigs being vaccinated annually in order to control the highly contagious virus that affects swine populations.
The global swine fever vaccine market is estimated to be valued at US$2885.25 million in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of African swine fever among pig farms has resulted in massive economic losses, subsequently driving demand for effective swine fever vaccines. As per data, China lost over a third of its pig population due to the ASF outbreak in 2018. Several initiatives taken by governments and international organizations to curb the spread of the disease has further boosted adoption. Industry players are focusing on developing improved live attenuated vaccines with high immunogenicity and safety. Rising livestock agriculture in developing nations also acts as a growth catalyst. However, stringent regulations pertaining to vaccine development may hinder market growth over the forecast period.
Segment Analysis
The global swine fever vaccine market is segmented by technology into attenuated live vaccine, killed vaccine and subunit vaccine. This is because subunit vaccines are made from purified antigen which reduces the risk of reverting to virulence, making them very safe to produce compared to live or inactivated vaccines.
Key Takeaways
The Global Swine Fever Vaccine Market Trend is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to increase from US$ 2885.25 Mn in 2023 registering a CAGR of 5.9% during the forecast period.
Regional analysis
The Asia Pacific region currently dominates the global swine fever vaccine market with a share of around 45% due to rising number of hog farms in major swine producing countries of China and Vietnam. The regional market is expected to witness the fastest growth over the forecast period supported by various government initiatives to prevent outbreaks of African swine fever virus.
Key players
Key players operating in the swine fever vaccine market include Merck & Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s., Komipharm, and EC21 Inc. Merck & Co. dominates the market with its DIVA-differentiable marker vaccines providing an efficacious and safe option for differentiating infected from vaccinated animals.
For more insights, read- https://www.dailyprbulletin.com/rising-incidence-of-african-and-classical-swine-fever-diseases-size
The latest trending report Global Classical Swine Fever Vaccines Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The Classical Swine Fever Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.This report also researches and evaluates the impact of Covid-19 outbreak on the Classical Swine Fever Vaccines industry, involving potential opportunity and challenges, drivers and risks.
We present the impact assessment of Covid-19 effects on Classical Swine Fever Vaccines and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.
).Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/29580-classical-swine-fever-vaccines-market-analysis-reportThe major players covered in Classical Swine Fever Vaccines are: WINSUN Veterinary MSD Animal Health CAHIC ChengDu Tecbond Merial Qilu Animal Ceva Chopper Biology Ringpu Biology Bioveta MVP DHN Jinyu Bio-Technology Agrovet CAVAC Tecon Institutul Pasteur KomipharmBy Type, Classical Swine Fever Vaccines market has been segmented into Tissue Culture Origin Cell Line OriginBy Application, Classical Swine Fever Vaccines has been segmented into: Government Tender Market SalesThe report offers in-depth assessment of the growth and other aspects of the Classical Swine Fever Vaccines market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, etc.
) Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)Download Free Sample Report of Global Classical Swine Fever Vaccines Market @ https://www.decisiondatabases.com/contact/download-sample-29580The content of the study subjects, includes a total of 15 chapters:Chapter 1, to describe Classical Swine Fever Vaccines product scope, market overview, market opportunities, market driving force and market risks.Chapter 2, to profile the top manufacturers of Classical Swine Fever Vaccines, with price, sales, revenue and global market share of Classical Swine Fever Vaccines in 2018 and 2019.Chapter 3, the Classical Swine Fever Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.Chapter 4, the Classical Swine Fever Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.Chapter 12, Classical Swine Fever Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.Chapter 13, 14 and 15, to describe Classical Swine Fever Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.Purchase the complete Global Classical Swine Fever Vaccines Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-29580All Vaccine Related Reports by DecisionDatabases.com @ https://goo.gl/Q2GmDtAbout-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Swine flu is infection of the respiratory system caused by influenza viruses.
These viruses also infect the respiratory system of pigs causing barking cough, decrease in appetite, nasal secretions, and listless behavior.
In April 2009, swine flu outbreak was first detected in Mexico and was caused due to the H1N1 virus.Read Report Overview - https://www.transparencymarketresearch.com/swine-flu-vaccine-market.html Symptoms of swine flu infection in humans are similar to influenza infection; these include cough, nasal secretions, headache, fatigue, and fever (temp.
The gestation period of the disease is around one to four days.
Vaccination is the best way to prevent the disease.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=33686 Influenza vaccine makes a significant division of global vaccine market.
In terms of end-user, the market can be divided into hospital pharmacies, retail pharmacies, online pharmacies, and clinic & vaccination centers.
The statistical surveying report on the global Classical Swine Fever Vaccines Market has been presented by using professional or expert knowledge through standard and modified research approaches and forecasts.
The yearly forecast and predication for the years 2020 to 2025 have been enclosed by the report along with comprehensive analysis for all market segments and regions.
The statistical data derived from authentic resources and assisted by industry experts.
It likewise assesses the market by evaluating market elements, including drivers, restraints, opportunities, threats, challenges, growth prospects, and other market elements.The global classical swine fever vaccines market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.Get FREE Sample Report Copy @ https://www.decisiondatabases.com/contact/download-sample-43045It is a type of vaccine for classical swine fever.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 59.6% in 2018.
